Free Trial

OraSure Technologies (OSUR) Competitors

OraSure Technologies logo
$3.12 0.00 (0.00%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$10.20 +7.08 (+226.92%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OSUR vs. STAA, CERS, UTMD, ANIK, WST, COO, ALGN, MMSI, HAE, and ICUI

Should you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include STAAR Surgical (STAA), Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry.

OraSure Technologies vs. Its Competitors

STAAR Surgical (NASDAQ:STAA) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

OraSure Technologies has lower revenue, but higher earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$313.90M4.26-$20.21M-$1.44-18.76
OraSure Technologies$185.83M1.26-$19.50M-$0.42-7.43

STAAR Surgical has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.27, meaning that its stock price is 73% less volatile than the S&P 500.

OraSure Technologies has a net margin of -19.77% compared to STAAR Surgical's net margin of -25.46%. OraSure Technologies' return on equity of -5.86% beat STAAR Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical-25.46% -10.59% -8.32%
OraSure Technologies -19.77%-5.86%-5.20%

STAAR Surgical presently has a consensus target price of $19.43, suggesting a potential downside of 28.10%. OraSure Technologies has a consensus target price of $3.00, suggesting a potential downside of 3.85%. Given OraSure Technologies' higher possible upside, analysts plainly believe OraSure Technologies is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
0 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.09
OraSure Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, STAAR Surgical had 7 more articles in the media than OraSure Technologies. MarketBeat recorded 17 mentions for STAAR Surgical and 10 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.46 beat STAAR Surgical's score of 0.41 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
2 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
OraSure Technologies
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by company insiders. Comparatively, 3.9% of OraSure Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

OraSure Technologies beats STAAR Surgical on 9 of the 16 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSUR vs. The Competition

MetricOraSure TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$233.38M$10.59B$5.59B$9.53B
Dividend YieldN/A2.00%4.73%4.14%
P/E Ratio-7.4319.2928.9123.88
Price / Sales1.2627.93448.7998.82
Price / Cash80.3622.1035.6858.35
Price / Book0.573.888.165.60
Net Income-$19.50M$211.77M$3.25B$265.26M
7 Day Performance-2.19%1.29%1.15%-0.14%
1 Month Performance1.30%4.55%8.25%6.08%
1 Year Performance-27.78%-10.58%29.18%24.22%

OraSure Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSUR
OraSure Technologies
2.1428 of 5 stars
$3.12
flat
$3.00
-3.8%
-26.2%$233.38M$185.83M-7.43840Trending News
STAA
STAAR Surgical
2.7914 of 5 stars
$19.25
+0.3%
$18.00
-6.5%
-27.0%$950.90M$313.90M-13.371,211Trending News
Analyst Forecast
Gap Up
CERS
Cerus
2.6207 of 5 stars
$1.36
-2.2%
$3.50
+157.4%
-42.3%$265.71M$180.27M-13.60290News Coverage
Positive News
Earnings Report
UTMD
Utah Medical Products
3.1945 of 5 stars
$57.77
-1.3%
N/A-13.6%$190.17M$40.90M15.45180Dividend Announcement
ANIK
Anika Therapeutics
4.4266 of 5 stars
$11.33
-1.5%
$20.00
+76.5%
-67.6%$164.93M$119.91M-2.92300Positive News
WST
West Pharmaceutical Services
4.5954 of 5 stars
$257.36
-2.3%
$320.71
+24.6%
-20.6%$18.93B$2.89B38.5310,600Positive News
Short Interest ↑
COO
Cooper Companies
3.2611 of 5 stars
$72.91
-2.3%
$96.73
+32.7%
-23.9%$14.92B$3.90B35.3916,000
ALGN
Align Technology
4.9446 of 5 stars
$207.19
+0.8%
$242.92
+17.2%
-32.8%$14.90B$4.00B37.7420,945Trending News
Earnings Report
Buyback Announcement
MMSI
Merit Medical Systems
4.5854 of 5 stars
$84.46
-0.3%
$109.11
+29.2%
-3.4%$5.01B$1.36B41.407,400Earnings Report
HAE
Haemonetics
4.864 of 5 stars
$74.66
-0.7%
$97.30
+30.3%
-12.1%$3.61B$1.36B22.563,023Positive News
Upcoming Earnings
ICUI
ICU Medical
4.6714 of 5 stars
$127.50
-1.8%
$192.67
+51.1%
+7.8%$3.20B$2.38B-33.2915,000Positive News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:OSUR) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners